View Older Stories View More Recent Stories

Nov 16, 2018 08:00AM Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th
Nov 16, 2018 08:00AM Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th
Nov 7, 2018 04:02PM Savara Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 7, 2018 04:02PM Savara Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 1, 2018 08:00AM Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018
Nov 1, 2018 08:00AM Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018
Oct 31, 2018 08:06AM Savara (SVRA) Reports Complete Enrollment in Molgradex OPTIMA Clinical Study for Treatment of NTM
Oct 31, 2018 08:00AM Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM
Oct 31, 2018 08:00AM Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM
Oct 15, 2018 08:02AM Savara (SVRA) Reports Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP
Oct 15, 2018 08:00AM Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP
Oct 15, 2018 08:00AM Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP
Sep 27, 2018 08:00AM Savara Provides Enrollment Update on Molgradex Impala and OPTIMA Clinical Studies and Reaffirms Guidance for Topline Data
Sep 27, 2018 08:00AM Savara Provides Enrollment Update on Molgradex Impala and OPTIMA Clinical Studies and Reaffirms Guidance for Topline Data
Sep 18, 2018 07:09AM BioTime (BTX) Names Brian Culley as CEO
Sep 18, 2018 07:00AM BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
Sep 18, 2018 07:00AM BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
Aug 27, 2018 08:00AM Savara Becomes Inaugural Foundation Sponsor of the PAP Foundation
Aug 27, 2018 08:00AM Savara Becomes Inaugural Foundation Sponsor of the PAP Foundation
Aug 9, 2018 04:03PM Savara Reports Second Quarter 2018 Financial Results and Provides Positive Business Update
Aug 9, 2018 04:03PM Savara Reports Second Quarter 2018 Financial Results and Provides Positive Business Update
Aug 2, 2018 08:00AM Savara to Host Second Quarter 2018 Financial Results and Business Update Conference Call on Thursday, August 9, 2018
Aug 2, 2018 08:00AM Savara to Host Second Quarter 2018 Financial Results and Business Update Conference Call on Thursday, August 9, 2018
Jul 25, 2018 04:01PM Savara Provides Positive Update on Development and Commercial Preparations of Molgradex, Including Expansion into NTM In CF
Jul 25, 2018 04:01PM Savara Provides Positive Update on Development and Commercial Preparations of Molgradex, Including Expansion into NTM In CF
Jul 23, 2018 08:00AM Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd
Jul 23, 2018 08:00AM Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd
Jun 25, 2018 08:00AM Savara Joins Russell 3000® Index
Jun 25, 2018 08:00AM Savara Joins Russell 3000® Index
Jun 13, 2018 08:00AM Savara to Present at JMP Securities 2018 Life Sciences Conference on June 20th
Jun 13, 2018 08:00AM Savara to Present at JMP Securities 2018 Life Sciences Conference on June 20th
May 29, 2018 08:05AM Savara (SVRA) Announces Update on Two Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor
May 29, 2018 08:00AM Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
May 29, 2018 08:00AM Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
May 15, 2018 12:26PM UPDATE -- Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 15th
May 15, 2018 12:26PM UPDATE -- Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 15th
May 11, 2018 08:00AM Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th
May 11, 2018 08:00AM Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th
May 11, 2018 08:00AM Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th
May 9, 2018 04:02PM Savara Reports First Quarter 2018 Financial Results and Provides Business Update
May 9, 2018 04:02PM Savara Reports First Quarter 2018 Financial Results and Provides Business Update
May 1, 2018 08:00AM Savara to Host First Quarter 2018 Financial Results and Business Update Conference Call on Wednesday, May 9, 2018
Mar 15, 2018 08:00AM Savara to Present at 28th Annual Oppenheimer & Co. Healthcare Conference on March 20th
Mar 14, 2018 04:05PM Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Mar 13, 2018 08:11AM Savara (SVRA) Initiates Phase 2a Clinical Study of Molgradex for Treatment of NTM Lung Infection
Mar 13, 2018 08:00AM Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
Mar 12, 2018 07:43AM Savara (SVRA) Says Aironite Fails to Meet Primary Endpoint in Indie Phase 2 Clinical Study (Earlier)
Mar 11, 2018 10:45AM Aironite Fails to Meet Primary Endpoint in the Indie Phase 2 Clinical Study Conducted by the Heart Failure Clinical Research Network
Mar 7, 2018 08:00AM Savara to Host Fourth Quarter & Fiscal Year End 2017 Financial Results and Business Update Conference Call on Wednesday March 14, 2018
Feb 16, 2018 08:11AM Savara (SVRA) Says Top Line Results From Aironite Phase 2 Clinical Trial for Treatment of HFpEF to Be Presented at ACC
View More Recent Stories View Older Stories